Federation des caisses Desjardins du Quebec’s Unity Biotechnology UBX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio UBX Stock Details UBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	-$3.86K	–	2464
2023 Q4	$3.86K	Buy	2,000 +1,800	+900%	+$3.35K	﹤0.01%	1966
2023 Q3	$480	Hold	200	–	–	﹤0.01%	2213
2023 Q2	$510	Hold	200	–	–	﹤0.01%	2191
2023 Q1	$326	Hold	200	–	–	﹤0.01%	2237
2022 Q4	$548	Sell	200 -300	-60%	-$872	﹤0.01%	2343
2022 Q3	$1.98K	Hold	500	–	–	﹤0.01%	2264
2022 Q2	$2.82K	Buy	500 +300	+150%	+$2.5K	﹤0.01%	2255
2022 Q1	$2.24K	Buy	+200	New	+$2.24K	﹤0.01%	2342
2021 Q3	–	Sell	-20	Closed	-$928	–	2617
2021 Q2	$928	Sell	20 -30	-60%	-$1.45K	﹤0.01%	2440
2021 Q1	$3K	Buy	+50	New	+$3.41K	﹤0.01%	2289

Other funds holding UBX

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's UBX Position: Q1 2024 in Review

Federation des caisses Desjardins du Quebec sold out of Unity Biotechnology (UBX) in Q1 2024, closing a stake of 2,000 shares — an estimated $3.86K sold.

Federation des caisses Desjardins du Quebec first reported a position in UBX in Q1 2021 and held it in 10 quarters. The position peaked at $3.86K in Q4 2023. 40 funds tracked by Wall St. Rank hold UBX as of Q1 2024.

Federation des caisses Desjardins du Quebec reported no remaining Unity Biotechnology position as of Q1 2024 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 2,000 Unity Biotechnology shares in Q1 2024, an estimated $3.86K.
Federation des caisses Desjardins du Quebec first reported a position in Unity Biotechnology in Q1 2021 and held it in 10 quarters.
Federation des caisses Desjardins du Quebec's Unity Biotechnology position peaked at $3.86K in Q4 2023.
40 funds tracked by Wall St. Rank held Unity Biotechnology as of Q1 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2024, filed 15 May 2024.